4/3
06:19 am
mnkd
MannKind Repays Certain Debt Obligations [Yahoo! Finance]
Low
Report
MannKind Repays Certain Debt Obligations [Yahoo! Finance]
4/3
06:00 am
mnkd
MannKind Repays Certain Debt Obligations
Low
Report
MannKind Repays Certain Debt Obligations
4/1
11:10 am
mnkd
MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns [Yahoo! Finance]
Low
Report
MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns [Yahoo! Finance]
3/26
04:18 pm
mnkd
MannKind Announces CFO Transition [Yahoo! Finance]
Medium
Report
MannKind Announces CFO Transition [Yahoo! Finance]
3/26
04:16 pm
mnkd
MannKind CFO Steven Binder to retire [Seeking Alpha]
Medium
Report
MannKind CFO Steven Binder to retire [Seeking Alpha]
3/26
04:05 pm
mnkd
MannKind Announces CFO Transition
Medium
Report
MannKind Announces CFO Transition
3/18
02:58 pm
mnkd
MannKind Co. (NASDAQ: MNKD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $6.50 price target on the stock.
Low
Report
MannKind Co. (NASDAQ: MNKD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $6.50 price target on the stock.
3/11
06:14 am
mnkd
INHALE-3 Study's Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps [Yahoo! Finance]
High
Report
INHALE-3 Study's Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps [Yahoo! Finance]
3/11
06:05 am
mnkd
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
High
Report
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
3/5
06:11 am
mnkd
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8 [Yahoo! Finance]
Low
Report
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8 [Yahoo! Finance]
3/5
06:05 am
mnkd
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
Low
Report
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
3/4
01:01 pm
mnkd
MannKind Corporation Announces Participation at Upcoming Conferences
Low
Report
MannKind Corporation Announces Participation at Upcoming Conferences
3/3
07:31 am
mnkd
Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts [Yahoo! Finance]
Low
Report
Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts [Yahoo! Finance]
2/28
05:12 pm
mnkd
MannKind Co. (NASDAQ: MNKD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Medium
Report
MannKind Co. (NASDAQ: MNKD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
2/28
12:14 pm
mnkd
MannKind Co. (NASDAQ: MNKD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $6.50 price target on the stock.
Low
Report
MannKind Co. (NASDAQ: MNKD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $6.50 price target on the stock.
2/28
09:46 am
mnkd
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/28
01:11 am
mnkd
MannKind (MNKD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
MannKind (MNKD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/27
07:13 pm
mnkd
Here's What Key Metrics Tell Us About MannKind (MNKD) Q4 Earnings [Yahoo! Finance]
Low
Report
Here's What Key Metrics Tell Us About MannKind (MNKD) Q4 Earnings [Yahoo! Finance]
2/27
07:13 pm
mnkd
MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Low
Report
MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
2/27
05:02 pm
mnkd
MannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023 [Yahoo! Finance]
Low
Report
MannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023 [Yahoo! Finance]
2/27
04:10 pm
mnkd
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update [Yahoo! Finance]
Low
Report
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update [Yahoo! Finance]
2/27
04:00 pm
mnkd
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
Medium
Report
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
2/20
06:00 am
mnkd
MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
Low
Report
MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
2/15
06:10 am
mnkd
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza® [Yahoo! Finance]
Low
Report
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza® [Yahoo! Finance]
2/15
06:05 am
mnkd
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
Medium
Report
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®